Related references
Note: Only part of the references are listed.Scutellaria barbata inhibits angiogenesis through downregulation of HIF-1 α in lung tumor
Ai-Li Shiau et al.
ENVIRONMENTAL TOXICOLOGY (2014)
Trial Watch Oncolytic viruses for cancer therapy
Jonathan Pol et al.
ONCOIMMUNOLOGY (2014)
Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma
Howard L. Kaufman et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2014)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Oncolytic Vaccinia Virus Disrupts Tumor-Associated Vasculature in Humans
Caroline J. Breitbach et al.
CANCER RESEARCH (2013)
Lin28 regulates BMP4 and functions with Oct4 to affect ovarian tumor microenvironment
Wei Ma et al.
CELL CYCLE (2013)
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
Jeong Heo et al.
NATURE MEDICINE (2013)
Predictive value of Sox2 expression in transurethral resection specimens in patients with T1 bladder cancer
Jun Ruan et al.
MEDICAL ONCOLOGY (2013)
Hypoxia-Inducible Factors Activate CD133 Promoter through ETS Family Transcription Factors
Shunsuke Ohnishi et al.
PLOS ONE (2013)
Nuclear Localization of COX-2 in relation to the Expression of Stemness Markers in Urinary Bladder Cancer
Raynoo Thanan et al.
MEDIATORS OF INFLAMMATION (2012)
The Hypoxia-Associated Factor Switches Cells from HIF-1α- to HIF-2α-Dependent Signaling Promoting Stem Cell Characteristics, Aggressive Tumor Growth and Invasion
Mei Yee Koh et al.
CANCER RESEARCH (2011)
A CD133-related gene expression signature identifies an aggressive glioblastoma subtype with excessive mutations
Xiaowei Yan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Novel Therapies Against Aggressive and Recurrent Epithelial Cancers by Molecular Targeting Tumor- and Metastasis-Initiating Cells and Their Progenies
Murielle Mimeault et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples
Angela Bentivegna et al.
CANCER SCIENCE (2010)
Virus therapy for bladder cancer
James Burke
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Current Issues and Future Directions of Oncolytic Adenoviruses
Masato Yamamoto et al.
MOLECULAR THERAPY (2010)
Embryonic stem cell markers expression in cancers
Matthieu Schoenhals et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells
Zhizhong Li et al.
CANCER CELL (2009)
Transthyretin-driven oncolytic adenovirus suppresses tumor growth in orthotopic and ascites models of hepatocellular carcinoma
Jeng-Long Hsieh et al.
CANCER SCIENCE (2009)
Adenovirus-Mediated Kallistatin Gene Transfer Ameliorates Disease Progression in a Rat Model of Osteoarthritis Induced by Anterior Cruciate Ligament Transection
Jeng-Long Hsieh et al.
HUMAN GENE THERAPY (2009)
Cancer stem cells: mirage or reality?
Piyush B. Gupta et al.
NATURE MEDICINE (2009)
Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells
Keith Syson Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells
Chao-Ching Chang et al.
CANCER RESEARCH (2008)
The role of hypoxia-inducible factors in tumorigenesis
E. B. Rankin et al.
CELL DEATH AND DIFFERENTIATION (2008)
Tumor-selective replication of an oncolytic adenovirus carrying Oct-3/4 response elements in murine metastatic bladder cancer models
Chao-Liang Wu et al.
CLINICAL CANCER RESEARCH (2008)
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy
Xiaoxian Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Hypoxia-inducible factors, stem cells, and cancer
Brian Keith et al.
CELL (2007)
OCT-4, an embryonic stem cell marker, is highly expressed in bladder cancer
Yaser Atlasi et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Hypoxia-inducible factor-1α is a key regulator of metastasis in a transgenic model of cancer initiation and progression
Debbie Liao et al.
CANCER RESEARCH (2007)
Hypoxia-induced cytosine deaminase gene expression for cancer therapy
Che-Hsin Lee et al.
HUMAN GENE THERAPY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Hypoxia-inducible factor-1 (HIF-1)
Qingdong Ke et al.
MOLECULAR PHARMACOLOGY (2006)
Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model
Gia-Shing Shieh et al.
CANCER RESEARCH (2006)
HIF-2α regulates Oct-4:: effects of hypoxia on stem cell function, embryonic development, and tumor growth
KL Covello et al.
GENES & DEVELOPMENT (2006)
Effect of hypoxia on Ad5 infection, transgene expression and replication
BH Shen et al.
GENE THERAPY (2005)
Hypoxia reduces adenoviral replication in cancer cells by downregulation of viral protein expression
T Pipiya et al.
GENE THERAPY (2005)
Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2α in von Hippel-Lindau renal cell carcinoma
BL Petrella et al.
ONCOGENE (2005)
Transductional and transcriptional targeting of adenovirus for clinical applications
JN Glasgow et al.
CURRENT GENE THERAPY (2004)
Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors
DE Post et al.
CLINICAL CANCER RESEARCH (2004)
Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor
WK Cho et al.
MOLECULAR THERAPY (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
A novel hypoxia-inducible factor (HIF) activated oncolytic adenovirus for cancer therapy
DE Post et al.
ONCOGENE (2003)
Human embryonic genes re-expressed in cancer cells
M Monk et al.
ONCOGENE (2001)
Share Paper
